{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T07:52:58Z","timestamp":1793778778963,"version":"4.6.1"},"reference-count":12,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,2]]},"abstract":"<jats:title>Abstract:<\/jats:title>\n          <jats:p>Eutectic mixture of 2.5% lidocaine and 2.5% prilocaine (EMLA AstraZeneca, DE) is a widely used topical anesthetic cream for preprocedural cutaneous analgesia. In addition to potential clinical cutaneous and systemic adverse effects, EMLA may also induce microscopic changes detectable by light and electron microscopy leading to difficulty in accurate diagnosis. We report the case of a biopsy demonstrating EMLA-induced histopathologic changes. The biopsy was taken from the back of a 5-month-old infant and submitted to rule out psoriasis. Hematoxylin and eosin (H&amp;E) staining of the biopsy demonstrated spongiosis and a noninflammatory subepidermal bulla, raising the histopathologic possibility of epidermolysis bullosa. Further investigation confirmed that EMLA was applied under occlusion before biopsy. A second biopsy without topical anesthetic did not demonstrate a bulla and supported the clinical diagnosis of psoriasiform dermatitis. Our case highlights the importance of awareness of EMLA-induced histopathologic changes to avoid potential misdiagnosis. The histopathologic findings of this case in conjunction with other previously reported cases of EMLA-induced bullae were analyzed. Vacuolization of the basal and suprabasilar layer, pallor and swelling of upper layer epidermal keratinocytes, a pauci-inflammatory cleavage beneath or within the basal layer, basophilic granular karyorrhectic debris in the subepidermal cleft, and congestion of papillary dermal vessels characterized the biopsy findings of this localized adverse reaction.<\/jats:p>","DOI":"10.1097\/dad.0000000000000670","type":"journal-article","created":{"date-parts":[[2016,11,10]],"date-time":"2016-11-10T15:55:01Z","timestamp":1478793301000},"page":"e19-e22","source":"Crossref","is-referenced-by-count":6,"title":["Pseudo-Bullous Dermatosis Induced by Topical Anesthetic Agent\u2014Clues to This Localized Toxic Reaction"],"prefix":"10.1097","volume":"39","author":[{"given":"Christopher R.","family":"Kieliszak","sequence":"first","affiliation":[{"name":"Department of Otolaryngology, Head and Neck Surgery, OhioHealth Doctors Hospital, Columbus, OH;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John R.","family":"Griffin","sequence":"additional","affiliation":[{"name":"Division of Dermatology, Baylor University Medical Center, Dallas, TX;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tess H.","family":"Pollinger","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Walter Reed National Military Medical Center, Bethesda, MD; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline M.","family":"Junkins-Hopkins","sequence":"additional","affiliation":[{"name":"Ackerman Academy of Dermatopathology, New York, NY."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"issue":"3 pt 1","key":"R1-20230908","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/S0190-9622(18)30741-2","article-title":"Prilocaine\/lidocaine patch as a local premedication for skin biopsy in children","volume":"37","author":"de Waard-van der Spek","year":"1997","journal-title":"J Am Acad Dermatol."},{"key":"R2-20230908","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1111\/cup.12155","article-title":"The spectrum of histopathologic patterns secondary to the topical application of EMLA(R) on vulvar epithelium: clinicopathological correlation in three cases","volume":"40","author":"Lewis","year":"2013","journal-title":"J Cutan Pathol."},{"key":"R3-20230908","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1111\/j.1600-0536.1994.tb00652.x","article-title":"Allergic contact dermatitis from prilocaine, one of the local anaesthetics in EMLA cream","volume":"30","author":"van den Hove","year":"1994","journal-title":"Contact Dermatitis"},{"key":"R4-20230908","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/j.1600-0536.2011.01944.x","article-title":"Acute bullous irritant contact dermatitis caused by EMLA(R) cream","volume":"65","author":"Kluger","year":"2011","journal-title":"Contact Dermatitis"},{"key":"R6-20230908","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1034\/j.1600-0560.2002.290312.x","article-title":"EMLA cream-induced irritant contact dermatitis","volume":"29","author":"Dong","year":"2002","journal-title":"J Cutan Pathol"},{"key":"R7-20230908","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1111\/j.1525-1470.2005.00142.x","article-title":"Purpura after application of EMLA cream in two children","volume":"22","author":"Neri","year":"2005","journal-title":"Pediatr Dermatol."},{"key":"R8-20230908","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1159\/000247857","article-title":"Local blanching after epicutaneous application of EMLA cream. A double-blind randomized study among 50 healthy volunteers","volume":"181","author":"Villada","year":"1990","journal-title":"Dermatologica"},{"key":"R9-20230908","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1111\/j.0105-1873.2004.00475.x","article-title":"Contact urticaria from Emla cream","volume":"51","author":"Waton","year":"2004","journal-title":"Contact Dermatitis"},{"key":"R10-20230908","first-page":"1118","article-title":"Risk of systemic toxicity with topical lidocaine\/prilocaine: a review","volume":"13","author":"Tran","year":"2014","journal-title":"J Drugs Dermatol."},{"key":"R11-20230908","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1111\/j.1600-0560.1999.tb01810.x","article-title":"Histopathology of an adverse reaction to a eutectic mixture of the local anesthetics lidocaine and prilocaine","volume":"26","author":"Hoss","year":"1999","journal-title":"J Cutan Pathol."},{"key":"R12-20230908","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1001\/archderm.143.8.1074","article-title":"Histologic cutaneous modifications after the use of EMLA cream, a diagnostic pitfall: review of 13 cases","volume":"143","author":"Cazes","year":"2007","journal-title":"Arch Dermatol."},{"key":"R13-20230908","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1023\/B:BOLI.0000037352.98317.5a","article-title":"Pseudo-lysosomal storage disease caused by EMLA cream","volume":"27","author":"Vallance","year":"2004","journal-title":"J Inherit Metab Dis."}],"container-title":["The American Journal of Dermatopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00000372-201702000-00020","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,8]],"date-time":"2023-09-08T04:08:17Z","timestamp":1694146097000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00000372-201702000-00020"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2]]},"references-count":12,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1097\/dad.0000000000000670","relation":{},"ISSN":["0193-1091"],"issn-type":[{"value":"0193-1091","type":"print"}],"subject":[],"published":{"date-parts":[[2017,2]]}}}